Current Appointments & Affiliations
Biostatistician, Senior
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy.
Journal Article Future Cardiol · December 2025 Full text Link to item CiteAssociation of Component Strategies of the Target Stroke Phase 3 Nationwide Quality Improvement Program With Accelerated Door-to-Puncture and Door-In-Door-Out Times for Ischemic Stroke Endovascular Thrombectomy in the United States.
Journal Article Circ Cardiovasc Qual Outcomes · November 2025 BACKGROUND: The Target Stroke Phase III program is a national quality improvement initiative led by the American Heart Association, which sought to improve the quality of care for patients with acute stroke undergoing acute reperfusion therapy including en ... Full text Link to item CiteEfficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy.
Journal Article N Engl J Med · January 11, 2024 BACKGROUND: Transthyretin amyloid cardiomyopathy is characterized by the deposition of misfolded monomeric transthyretin (TTR) in the heart. Acoramidis is a high-affinity TTR stabilizer that acts to inhibit dissociation of tetrameric TTR and leads to more ... Full text Link to item CiteRecent Grants
Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation
ResearchBiostatistician · Awarded by University of Texas Southwestern Medical Center · 2022 - 2026The Impact of Quality Metrics on Outcomes among Elderly Heart Failure Patients
ResearchStatistician · Awarded by Dartmouth College · 2019 - 2021Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation
ResearchStatistician · Awarded by National Institutes of Health · 2020 - 2021View All Grants